{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:45:55Z","timestamp":1792673155396,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The role of genetics in breast cancer management is becoming increasingly essential in sub-Saharan Africa (SSA). Harmonized Guidelines by the National Comprehensive Cancer Network (NCCN) for SSA outline the subset of patients requiring genetic testing for hereditary breast cancer as part of their treatment plan. However, in low-and middle-income countries (LMICs) like Nigeria, access to genetic counselling and testing remains limited. Additionally, the knowledge and acceptability of these available services from the healthcare provider (HCP) perspective are largely unknown. This study aimed to assess the knowledge and perceptions of hereditary breast cancer testing among HCPs in Nigeria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In June 2022, we conducted a survey among 549 Nigerian HCPs. The 35-item survey was administered using Google Forms and distributed via WhatsApp. The survey collected demographic data and included three sections on genetic testing in breast cancer patients, focusing on knowledge, perceptions, and training.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results were analyzed using R Version 4.4.1 (R Core Team). Altogether 121 HCPs responded (22% response rate): 54 (44.6%) general surgeons, 4 (3.3%) breast surgical oncologists, 29 (24.0%) clinical and radiation oncologists, 31(25.6%) oncology nurses, and 3 (2.5%) breast radiologists. The survey results indicate that Nigerian HCPs were knowledgeable about hereditary breast cancer genetics, but the implementation of counselling and testing was low. Only 32.2% of respondents had requested genetic testing for their patients, and all testing was done through private laboratories. Only 9.9% had received formal clinical genetics training, and 13.2% reported having a genetic counsellor in their hospital. There was considerable interest in future genetics training programs using in person and online teaching modalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This survey highlights the need for specialized breast cancer genetic training tailored for Nigerian HCPs, which is essential in achieving breast cancer treatment parity. Addressing the substantial challenges in expanding genetic testing capacity in Nigeria is warranted for future progress.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13053-025-00315-w","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:29:37Z","timestamp":1747639777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Knowledge and perceptions of genetic testing for patients with breast cancer in Nigeria: a survey of healthcare providers"],"prefix":"10.1186","volume":"23","author":[{"given":"Funmilola Olanike","family":"Wuraola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenine","family":"Ramruthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Reel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folorunso","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agodirin","family":"Olayide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Sunday-Nweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun","family":"Alatise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin D.","family":"Cil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"5","key":"315_CR1","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/j.canep.2012.04.007","volume":"36","author":"E Jedy-Agba","year":"2012","unstructured":"Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, et al. Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol. 2012;36(5):e271\u20138.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"315_CR2","first-page":"9943247","volume":"2022","author":"A Ntekim","year":"2022","unstructured":"Ntekim A, Oluwasanu M, Odukoya O. Breast cancer in adolescents and young adults less than 40 years of age in Nigeria: A retrospective analysis. Int J Breast Cancer. 2022;2022(1):9943247.","journal-title":"Int J Breast Cancer"},{"issue":"12","key":"315_CR3","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/ijc.33484","volume":"148","author":"O Olasehinde","year":"2021","unstructured":"Olasehinde O, Alatise O, Omisore A, Wuraola F, Odujoko O, Romanoff A, et al. Contemporary management of breast cancer in Nigeria: insights from an institutional database. Int J Cancer. 2021;148(12):2906\u201314.","journal-title":"Int J Cancer"},{"key":"315_CR4","unstructured":"Ellison LF, Saint-Jacques N, Statistics Canada. 2023. Five-year cancer survival by stage at diagnosis in Canada. Available from: https:\/\/www150.statcan.gc.ca\/n1\/pub\/82-003-x\/2023001\/article\/00001-eng.htm."},{"issue":"3","key":"315_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"315_CR6","unstructured":"Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, et al. NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. J Natl Compr Canc Netw. 2023;21(10):1000\u201310."},{"issue":"1","key":"315_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41525-018-0046-7","volume":"3","author":"AE Toland","year":"2018","unstructured":"Toland AE, Forman A, Couch FJ, Culver JO, Eccles DM, Foulkes WD, et al. Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices. NPJ Genomic Med. 2018;3(1):7.","journal-title":"NPJ Genomic Med"},{"key":"315_CR8","doi-asserted-by":"crossref","unstructured":"Forbes C, Fayter D, de Kock S, Quek RG. A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer. Cancer Manag Res. 2019;11:2321\u201337.","DOI":"10.2147\/CMAR.S189627"},{"key":"315_CR9","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, et al. Consensus guidelines on genetictesting for hereditary breast cancer from the American society of breast surgeons. Ann Surg Oncol. 2019;26:3025\u201331.","journal-title":"Ann Surg Oncol"},{"key":"315_CR10","doi-asserted-by":"crossref","unstructured":"Bedrosian I, Somerfield MR, Achatz MI, Boughey JC, Curigliano G, Friedman S, et al. Germline testing in patients with breast cancer: ASCO\u2013Society of surgical oncology guideline. J Clin Oncol. 2024;42(5):584\u2013604.","DOI":"10.1200\/JCO.23.02225"},{"issue":"1","key":"315_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/njcp.njcp_437_20","volume":"25","author":"A Liman","year":"2022","unstructured":"Liman A, Kabir B, Abubakar M, Abdullahi S, Ahmed S, Shehu S. Triple-Negative breast Cancer (TNBC) and its luminal androgen receptor (LAR) subtype: A clinicopathologic review of cases in a university hospital in Northwestern Nigeria. Niger J Clin Pract. 2022;25(1):97\u2013104.","journal-title":"Niger J Clin Pract"},{"issue":"10","key":"315_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/modpathol.3800453","volume":"18","author":"E Honrado","year":"2005","unstructured":"Honrado E, Ben\u00edtez J, Palacios J. The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol. 2005;18(10):1305\u201320.","journal-title":"Mod Pathol"},{"issue":"28","key":"315_CR13","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1200\/JCO.2018.78.3977","volume":"36","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Walsh T, Gulsuner S, Casadei S, Lee MK, Ogundiran TO, et al. Inherited breast cancer in Nigerian women. J Clin Oncol. 2018;36(28):2820.","journal-title":"J Clin Oncol"},{"issue":"16","key":"315_CR14","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","volume":"66","author":"KE Malone","year":"2006","unstructured":"Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 2006;66(16):8297\u2013308.","journal-title":"Cancer Res"},{"issue":"23","key":"315_CR15","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1002\/cncr.29645","volume":"121","author":"T Pal","year":"2015","unstructured":"Pal T, Bonner D, Cragun D, Monteiro ANA, Phelan C, Servais L, et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer. 2015;121(23):4173\u201380.","journal-title":"Cancer"},{"issue":"23","key":"315_CR16","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316.","journal-title":"JAMA"},{"key":"315_CR17","doi-asserted-by":"publisher","first-page":"e2100140","DOI":"10.1200\/GO.21.00140","volume":"9","author":"PO Adejumo","year":"2023","unstructured":"Adejumo PO, Aniagwu TI, Awolude OA, Adedokun B, Kochheiser M, Sowunmi A, et al. Cancer genetic services in a low-to middle-income country: cross-sectional survey assessing willingness to undergo and pay for germline genetic testing. JCO Glob Oncol. 2023;9:e2100140.","journal-title":"JCO Glob Oncol"},{"key":"315_CR18","doi-asserted-by":"crossref","unstructured":"Adejumo PO, Aniagwu TI, Awolude OA, Oni AO, Ajayi OO, Fagbenle O, et al. Feasibility of genetic testing for cancer risk assessment programme in Nigeria. Ecancermedicalscience. 2021;15:1283.","DOI":"10.3332\/ecancer.2021.1283"},{"key":"315_CR19","first-page":"1","volume":"4","author":"P Adejumo","year":"2018","unstructured":"Adejumo P, Aniagwu T, Oluwatosin A, Fagbenle O, Ajayi O, Ogungbade D, et al. Knowledge of genetic counseling among patients with breast cancer and their relatives at a Nigerian teaching hospital. J Glob Oncol. 2018;4:1\u20138.","journal-title":"J Glob Oncol"},{"key":"315_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10897-017-0194-4","volume":"27","author":"SO Ngene","year":"2018","unstructured":"Ngene SO, Adedokun B, Adejumo P, Olopade O. Breast cancer genetics knowledge and testing intentions among Nigerian professional women. J Genet Couns. 2018;27:863\u201373.","journal-title":"J Genet Couns"},{"key":"315_CR21","unstructured":"SYNLAB Hereditary Breast. Ovarian Cancer Test. Available from: https:\/\/www.synlab.com.ng\/all-tests\/?search=hereditary+breast%2c+ovarian+cancer+%28brca1+%26+brca2+ngs%2bmlpa%29."},{"issue":"24","key":"315_CR22","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.3390\/jcm11247502","volume":"11","author":"C Saccardi","year":"2022","unstructured":"Saccardi C, Spagnol G, Saibene T, De Lorenzo LS, Marchetti M, Bonaldo G, et al. Risk-Reducing Salpingo-Oophorectomy (RRSO) combined with simultaneous mastectomy in women with BRCA 1\u20132 mutation carriers: the surgical technique, the feasibility and patients\u2019 satisfaction of multiple surgeries. J Clin Med. 2022;11(24):7502.","journal-title":"J Clin Med"},{"key":"315_CR23","unstructured":"Oguntola AS, Olaitan PB, Omotoso O, Oseni GO. Knowledge, attitude and practice of prophylactic mastectomy among patients and relations attending a surgical outpatient clinic. Pan Afr Med J. 2012;13:20."},{"issue":"10","key":"315_CR24","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","volume":"22","author":"MD Schwartz","year":"2004","unstructured":"Schwartz MD, Lerman C, Brogan B, Peshkin BN, Hughes Halbert C, DeMarco T, et al. Impact of BRCA1 \/ BRCA2 counseling and testing on newly diagnosed breast Cancer patients. J Clin Oncol. 2004;22(10):1823\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"315_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1007\/s00268-018-04897-6","volume":"43","author":"CH Yip","year":"2019","unstructured":"Yip CH, Evans DG, Agarwal G, Buccimazza I, Kwong A, Morant R, et al. Global disparities in breast Cancer genetics testing, counselling and management. World J Surg. 2019;43(5):1264\u201370.","journal-title":"World J Surg"},{"issue":"3","key":"315_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/mgg3.419","volume":"6","author":"AA Adeyemo","year":"2018","unstructured":"Adeyemo AA, Amodu OK, Ekure EE, Omotade OO. Medical genetics and genomic medicine in Nigeria. Mol Genet Genomic Med. 2018;6(3):314.","journal-title":"Mol Genet Genomic Med"},{"key":"315_CR27","doi-asserted-by":"crossref","unstructured":"Hayat M, Chen WC, Brandenburg JT, de Villiers CB, Ramsay M, Mathew CG. Genetic susceptibility to breast Cancer in Sub-Saharan African populations. JCO Glob Oncol. 2021;7:1462\u201371.","DOI":"10.1200\/GO.21.00089"},{"issue":"3","key":"315_CR28","first-page":"267","volume":"22","author":"BA Glenn","year":"2012","unstructured":"Glenn BA, Chawla N, Bastani R. Barriers to genetic testing for breast Cancer risk among ethnic minority women. Ethn Dis. 2012;22(3):267\u201373.","journal-title":"Ethn Dis"},{"issue":"1","key":"315_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/jcls.jcls_6_20","volume":"18","author":"OJ Afolaranmi","year":"2021","unstructured":"Afolaranmi OJ, Salako O, Okunade KS, James AB, Fagbenro GT. Integrating genomics education into Nigerian undergraduate medical training-a narrative review. J Clin Sci. 2021;18(1):3\u20137.","journal-title":"J Clin Sci"},{"key":"315_CR30","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1200\/EDBK_238937","volume":"39","author":"SA Cohen","year":"2019","unstructured":"Cohen SA, Bradbury A, Henderson V, Hoskins K, Bednar E, Arun BK. Genetic counseling and testing in a community setting: quality, access, and efficiency. Am Soc Clin Oncol Educ Book. 2019;39:e34\u201344.","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-025-00315-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13053-025-00315-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-025-00315-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:29:41Z","timestamp":1747639781000},"score":1,"resource":{"primary":{"URL":"https:\/\/hccpjournal.biomedcentral.com\/articles\/10.1186\/s13053-025-00315-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1186\/s13053-025-00315-w","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}